Clinical Trials Browser

Withdrawn × NIH × palbociclib × Clear all

NCT03377101 2018-08-14

Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast Cancer

Phase 2 Withdrawn

Estrogen Receptor Positive